Research ArticleArticle
Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors
Ralph Laufer, Odalys Gonzalez Paz, Annalise Di Marco, Fabio Bonelli, Edith Monteagudo, Vincenzo Summa and Michael Rowley
Drug Metabolism and Disposition April 2009, 37 (4) 873-883; DOI: https://doi.org/10.1124/dmd.108.023804
Ralph Laufer
Odalys Gonzalez Paz
Annalise Di Marco
Fabio Bonelli
Edith Monteagudo
Vincenzo Summa
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors
Ralph Laufer, Odalys Gonzalez Paz, Annalise Di Marco, Fabio Bonelli, Edith Monteagudo, Vincenzo Summa and Michael Rowley
Drug Metabolism and Disposition April 1, 2009, 37 (4) 873-883; DOI: https://doi.org/10.1124/dmd.108.023804
Research ArticleArticle
Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors
Ralph Laufer, Odalys Gonzalez Paz, Annalise Di Marco, Fabio Bonelli, Edith Monteagudo, Vincenzo Summa and Michael Rowley
Drug Metabolism and Disposition April 1, 2009, 37 (4) 873-883; DOI: https://doi.org/10.1124/dmd.108.023804
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement